MDMG.L Regulatory News (MDMG)

MD MEDICAL GROUP

ANNOUNCEMENT OF THE ANNUAL GENERAL MEETING

28 April 2015, Moscow, Russia - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), Russia's leading provider of private women's and children's healthcare, announces that at a meeting on April 27th, 2015 the Board of Directors of MD Medical Group Investments Plc called an Annual General Meeting of shareholders to be held at Lapino hospital, Lapino 111, Odinzovskiy district, Moscow Region, Russian Federation on June 05, 2015 at 10.00 a.m. local time, to consider and, if thought fit, pass resolutions 1 to 6, being items of ordinary business as follows:

1. To receive and consider the consolidated financial statements of the Company for the financial year ended 31 December 2014, together with the reports of the directors and independent auditors.

2. To appoint auditors of the Company, to hold office until the conclusion of the next annual general meeting of the Company and to authorize the Board of Directors to determine the remuneration of the auditors.

3. To appoint Mr. Vitaly Ustimenko as a director of the Company without remuneration, to hold such office until the conclusion of the annual general meeting of the Company to be held in 2018.

4. To appoint Mrs. Liubov Malyarevskaya as a director of the Company with an annual gross remuneration of RUB 862,069 (approx. GBP 11,350), to hold such office until the conclusion of the annual general meeting of the Company to be held in 2018.

5. To appoint Mr. Vladimir Mekler as a director of the Company without remuneration, to hold such office until the conclusion of the annual general meeting of the Company to be held in 2018.

6. The payment of a dividend, out of the profits made during the year 2014, in the amount of RUB 4.01 per share, as proposed in the directors' report be and is hereby approved.

The record date to participate the Annual General Meeting of shareholders shall be May 08, 2015.

Subject to shareholders' approval of the dividend at the annual general meeting of shareholders of the Company, the dividend record date is set as June 05, 2015. The Global Depository Receipts will be marked as ex-dividend on June 04, 2015. The pay date for GDR holders is tentatively set as July 03, 2015.

Annex to the Notice of Annual General Meeting:

Brief biographies of the candidates for the Board of Directors

Mr. Vitaly Ustimenko

Mr Vitaly Ustimenko joined the Group as Chief Financial Officer in 2012. Mr Ustimenko has more than fourteen years of experience in finance. Previously he was the Head of Strategic and Business Planning of OAO Russian Helicopters and before that held the position of Senior Manager at Deloitte Tohmatsu Limited. Mr Ustimenko holds a bachelor's degree from the Finance University under the Government of the Russian Federation and a PhD in finance from the State University of Management.

Mrs. Liubov Malyarevskaya

Mrs. Liubov Malyarevskaya has been a Project Director at Finance department of JSC "Sberbank Russia" since 2014. Earlier, from 2011 to 2014, Mrs Malyarevskaya was a partner and head of the Corporate Finance Department of JSC "BDO". From 2001 through 2010 she worked at PricewaterhouseCoopers and Deloitte., including as senior manager at Deloitte Touche Tomatsu Ltd. Mrs Malyarevskaya holds a Russian Statutory Accountant Certificate as well as a certificate from the Association of Chartered Certified Accountants (ACCA). Mrs. Malyarevskaya graduated from the Plekhanov Russian Academy of Economics (diploma cum laude).

Mr. Vladimir Mekler

Mr Vladimir Mekler is a senior and managing partner of "Mekler&Partners". Mr Mekler specializes in corporate law, including support and structuring of complex contracts, cross-border contracts among others; systems of corporate governance and legal structuring development and optimization with regards to criminal and antitrust legislation; legal support of mergers and acquisitions; corporate disputes settlement; organization and coordination of legal representation and defence in repeat economic and property crimes. Mr Mekler has been a member of the Moscow City Bar since 1980 and is listed in the Moscow Bar's Book of Honours. He also acted as Vice-chairman of the Presidium of the Moscow City Bar Association from 2003 to 2010. He graduated from the Lomonosov Moscow State University.

For further information please contact:

About MD Medical Group

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 23 modern healthcare facilities, including 4 hospitals and 19 outpatient clinics in Moscow, St. Petersburg, Ufa, Perm, Samara and Samara region, Novosibirsk, Irkutsk, Yaroslavl and Ryazan. In addition, 3 franchised outpatient clinics operate in Kyiv, Ukraine.

In 2014, there were 4,550 deliveries; IVF cycles amounted to 7,654. Number of outpatient treatments totalled 818,636 and number of in-patient days reached 35,900.

 The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

Forward-Looking Statements:

This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.

No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.